announcement, page-17

I feel that ANP has really escaped the market.Given that ATL1101 is an ANTI CANCER drug this will really start to bring ANP in with the high end of the boi stocks.PROSTRATE CANCER is one of the most common cancers and a possible cure via ATL1101 would simply be enormous globally.
This is the start for ANP to be a successful pharmaceutical company.

Robssstttaaarrrrr

Antisense Therapeutics Limited (ASX:ANP) is pleased to announce that it has executed an agreement for
an exclusive Option to License the Company?s second generation antisense compound ATL1101 with
privately-owned Australian biotechnology firm, Afandin Pty. Ltd. (Afandin), founded by Dr Ian Nisbet,
PhD, MAICD and Dr Anthony Filippis, PhD, MBA, both highly experienced biotechnology business
executives with a strong track record in cancer drug development and commercialisation